Cases & Deals

Share

Abiomed invests in Protembis

October 2018

Client(s) Abiomed, Inc.

Jones Day advised Abiomed, Inc., a U.S. listed medtech company, in connection with its purchase of Series A Preferred Stock in a private placement by Protembis GmbH, a medical device start-up company based in Aachen, Germany.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.